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Early mammalian embryogenesis is controlled by mechanisms governing the balance between
pluripotency and differentiation. The expression of early lineage-speciﬁc genes can vary signiﬁcantly
between species, with implications for developmental control and stem cell derivation. However, the
mechanisms involved in patterning the human embryo are still unclear. We analyzed the appearance
and localization of lineage-speciﬁc transcription factors in staged preimplantation human embryos
from the zygote until the blastocyst. We observed that the pluripotency-associated transcription
factor OCT4 was initially expressed in 8-cell embryos at 3 days post-fertilization (dpf), and restricted to
the inner cell mass (ICM) in 128–256 cell blastocysts (6 dpf), approximately 2 days later than the
mouse. The trophectoderm (TE)-associated transcription factor CDX2 was upregulated in 5 dpf
blastocysts and initially coincident with OCT4, indicating a lag in CDX2 initiation in the TE lineage,
relative to the mouse. Once established, the TE expressed intracellular and cell-surface proteins
cytokeratin-7 (CK7) and ﬁbroblast growth factor receptor-1 (FGFR1), which are thought to be speciﬁc to
post-implantation human trophoblast progenitor cells. The primitive endoderm (PE)-associated transcrip-
tion factor SOX17 was initially heterogeneously expressed in the ICM where it co-localized with a sub-set
of OCT4 expressing cells at 4–5 dpf. SOX17 was progressively restricted to the PE adjacent to the blastocoel
cavity together with the transcription factor GATA6 by 6 dpf. We observed low levels of Laminin expression
in the human PE, though this basement membrane component is thought to play an important role in
mouse PE cell sorting, suggesting divergence in differentiation mechanisms between species. Additionally,
while stem cell lines representing the three distinct cell types that comprise a mouse blastocyst have been
established, the identity of cell types that emerge during early human embryonic stem cell derivation is
unclear. We observed that derivation from plating intact human blastocysts resulted predominantly in the
outgrowth of TE-like cells, which impairs human embryonic stem cell derivation. Altogether, our ﬁndings
provide important insight into developmental patterning of preimplantation human embryos with
potential consequences for stem cell derivation.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human and mouse embryo development begins in transcrip-
tional silence with an oocyte to zygotic transition. This encom-
passes fertilization and karyogamy, epigenetic reprogramming, a
series of cleavage divisions and embryonic genome activationll rights reserved.
ry for Regenerative Medicine,
Robinson Way, Cambridge,
,(EGA). The ﬁrst molecular difference is the timing of EGA, which
initiates between the 1- and 2-cell stage for mice (Flach et al.,
1982; Wang et al., 2004), and the 4- and 8-cell stage for humans
(Braude et al., 1988; Tesarik et al., 1988). A compacted morula
forms following EGA marking the ﬁrst morphological indication of
a break in radial symmetry.
Subsequent cell divisions and cavitation lead to the formation
of the blastocyst comprised of a ﬂuid-ﬁlled blastocoel cavity and
an inner cell mass (ICM), surrounded by trophectoderm (TE) cells.
Humans lag behind mice in the timing of blastocyst formation,
which corresponds to 3–3.5 days post-fertilization (dpf) in mice
in contrast to 4–5 dpf in humans (Brinster, 1963; Hertig et al.,
1959; Steptoe et al., 1971). At the time of implantation into the
maternal uterus, the ICM is comprised of epiblast progenitor and
K.K. Niakan, K. Eggan / Developmental Biology 375 (2013) 54–64 55primitive endoderm (PE) cells. Mouse blastocysts implant at
approximately 4–4.5 dpf, whereas human embryos undergo at
least one additional cell division and implant between 6 and 8 dpf
(Cockburn and Rossant, 2010; Finn and McLaren, 1967; Hertig
et al., 1959; Niakan et al., 2012; Norwitz et al., 2001). Lineage
studies in mice indicate that after implantation TE cells contribute
to the placenta, PE cells contribute principally to the yolk sac and
epiblast progenitor cells contribute to the fetus and extraem-
bryonic mesoderm (Gardner, 1985; Gardner et al., 1973; Gardner
and Rossant, 1979; Papaioannou et al., 1975).
In mice, the octamer-binding transcription factor Oct4 (also
known as Pou5f1) is required for the formation of the ICM, while
the caudal-like transcription factor Cdx2 is required for TE develop-
ment (Chawengsaksophak et al., 1997; Nichols et al., 1998; Strumpf
et al., 2005). Zygotic Oct4 mRNA and protein are initially expressed in
all cells of mouse embryos from the 4-cell (Nichols et al., 1998) and 8-
cell stage, respectively (Liu et al., 2004; Palmieri et al., 1994).
Similarly, Oct4 protein was detected in 8-cell bovine embryos
(Khan et al., 2012). Variable (mosaic, detectable and undetectable)
Cdx2 protein expression has been noted in mouse embryos at the 8-
cell stage (Ralston and Rossant, 2008) and Cdx2 is detectable in the
nucleus of 16-cell morulae at 2.5 dpf (Dietrich and Hiiragi, 2007;
Jedrusik et al., 2010; Ralston and Rossant, 2008; Strumpf et al., 2005).
CDX2 expression in the cow follows blastocyst formation at approxi-
mately 5 dpf (Berg et al., 2011). However, it is unclear when
embryonic OCT4 or CDX2 protein expression is initiated in the human
embryo and whether their expression resembles the mouse or the
cow. Later in development, Oct4/OCT4 co-localizes with Cdx2/CDX2
in the TE of mouse, the cow, pig and human embryos (Berg et al.,
2011; Chen et al., 2009; Dietrich and Hiiragi, 2007; Kuijk et al., 2008;
Pant and Keefer, 2009; Ralston and Rossant, 2008). Species-speciﬁc
differences in the timing of the restriction of these key developmental
regulators to the respective ICM and TE have been noted. For
example, in contrast to mouse embryos where Oct4 expression is
downregulated in the TE of blastocysts by 4.5 dpf (Dietrich and
Hiiragi, 2007; Grabarek et al., 2012; Palmieri et al., 1994) human,
cow, pig and rhesus monkey blastocysts have persistent OCT4 protein
expression in the TE until 6–10 dpf, depending on the species (Berg
et al., 2011; Cauffman et al., 2006; Chen et al., 2009; Harvey et al.,
2009; Kirchhof et al., 2000; Kuijk et al., 2008; Mitalipov et al., 2003;
Pant and Keefer, 2009; van Eijk et al., 1999). Altogether, this suggest
that the segregation of the TE and ICM may be initiated just prior to
implantation in many species, including humans, and that there may
be species-speciﬁc differences in the appearance and localization of
lineage specifying factors.
The earliest known event inﬂuencing differentiation of the mouse
ICM into its two distinct components, the epiblast and PE, is signaling
through the ﬁbroblast growth factor (FGF)/Erk pathway that leads to
expression of the GATA transcription factors, Gata6 and Gata4, which
are eventually restricted to the PE (Arman et al., 1998; Chazaud et al.,
2006; Cheng et al., 1998; Feldman et al., 1995). More recently, we and
others have demonstrated that the SRY HMG homeobox transcription
factor, Sox17 also functions in specifying PE cells from epiblast cells
within the ICM (Artus et al., 2011; Morris et al., 2010; Niakan et al.,
2010). It is thought that the inhibitory interactions between PE
transcription factors Gata6/Gata4/Sox17 oppose the expression of
the epiblast-associated transcription factor Nanog that eventually
compartmentalizes the ICM into distinct domains (Artus et al., 2011;
Chazaud et al., 2006; Morris et al., 2010; Niakan et al., 2010; Plusa
et al., 2008). These mechanisms are thought in part to be facilitated
by expression of a cell-surface extracellular matrix protein Laminin
and the receptor tyrosine kinase Pdgfra (Chazaud et al., 2006; Niakan
et al., 2010; Plusa et al., 2008; Yamanaka et al., 2006). Consistent with
studies in the mouse (Chazaud et al., 2006; Plusa et al., 2008), GATA6
is expressed broadly in the human embryo (Kimber et al., 2008; Kuijk
et al., 2012; Roode et al., 2012). In late-blastocysts GATA4, GATA6 andSOX17 are restricted to a subset of putative PE cells in human
embryos that lack NANOG expression (Kuijk et al., 2012; Roode
et al., 2012). While mosaic expression of GATA6 and NANOG has been
shown in human mid-blastocysts (Roode et al., 2012), PE-associated
protein expression has not been reported prior to the mid- to late-
blastocyst and it remains unclear whether additional PE-associated
genes, such as SOX17, are also heterogeneously expressed in the early
human ICM.
Human embryonic stem cell (hESC) lines established from the
ICM of preimplantation embryos (Thomson et al., 1998) are a
tractable system for understanding molecular mechanisms of
early embryogenesis and have tremendous potential in
medical applications. Typically, hESC derivation involves isolating
the human ICM either by chemical-based immunosurgery
(Reubinoff et al., 2000; Solter and Knowles, 1975; Thomson
et al., 1998) or laser-mediated TE ablation (Chen et al., 2009;
Turetsky et al., 2008). hESCs have also been derived, although
with lower efﬁciency, from intact blastocysts by isolating
adherent ICM outgrowths prior to differentiation (Baharvand
et al., 2004; Chen et al., 2009; Genbacev et al., 2005; Heins
et al., 2004). Although ICM isolation signiﬁcantly improves hESC
derivation efﬁciency, it remains unclear what cell types emerge
during early stem cell derivation from plated whole blastocysts
and whether these cells may be promoted to self-renew as either
hESCs or extraembryonic stem cells. We investigated the implica-
tion of the presence of extraembryonic cells in blastocyst out-
growths during hESC derivation. In contrast to stem cell
derivation from plated mouse blastocysts, we found that although
human extraembryonic cells initially proliferate, they cannot be
maintained and negatively affect hESC derivation, underscoring
the importance for ICM isolation.
To further understand lineage speciﬁcation in the human
preimplantation embryo we analyzed OCT4, CDX2 and SOX17
protein distribution from the zygote until the blastocyst. We
observed that OCT4 was initially detectable at the 7 or 8-cell
stage following EGA and was persistently expressed in the
TE of blastocysts. SOX17 and CDX2 were detectable in the
blastocyst at approximately 5 dpf, where they initially
co-localize with OCT4 in the PE and TE, respectively. OCT4
expression in human embryos was primarily restricted to the
ICM in late-blastocysts and downregulated in a subset of PE
cells, which is consistent with recent observations (Roode
et al., 2012) and similar to the mouse late-blastocyst
(Grabarek et al., 2012). To understand the dynamics of
pluripotency-associated gene expression we analyzed NANOG
expression, which we conﬁrm was restricted to the ICM prior
to OCT4 (Kimber et al., 2008; Roode et al., 2012). To further
understand human TE cell identity, we analyzed the expres-
sion of proteins identiﬁed in the post-implantation tropho-
blast such as cytokeratin-7 (CK7) and ﬁbroblast growth factor
receptor-1 (FGFR1), which were expressed in preimplantation
human embryos. In all, our study signiﬁcantly expands the
characterization of protein expression patterns throughout
human preimplantation development revealing unique prop-
erties of human embryogenesis that have important implica-
tions for stem cell derivation.Materials and methods
All experiments were performed using human embryos that
were excess to infertility treatment and donated for research
following informed consent in accordance with the guidelines
established by the Harvard University Embryonic Stem Cell
Research Oversight (ESCRO) Committee and the Committee on
the Use of Human Subjects Institutional Review Board (IRB).
Fig. 1. Human blastocyst formation precedes CDX2 expression in the trophecto-
derm, where OCT4 persists. (A) Optical sections and 3D projections of immunostained
human preimplantation embryos at deﬁned stages of development. The number of
days post-fertilization (dpf) and the approximate cell number is indicated for each
embryo. OCT4 (green), CDX2 (red) and DAPI (blue) nuclear staining. Scale bar is
100 mm. (B) Quantiﬁcation of the total number of OCT4 (dark blue bar) and CDX2
(medium blue bar) expressing cells as a percentage of total DAPI-expression. The
percentage of CDX2 expressing cells that overlap with the expression of OCT4 is
indicated by the light blue bar. Data are the mean7standard deviation of biological
replicates.
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Cleavage or blastocyst stage human embryos were thawed
using Quinn’s Advantage Thaw Kit (Sage) according to the
manufacturer’s instructions. Embryos were cultured in Global
Media (LifeGlobal) supplemented with 15% plasminate (Telacris)
under mineral oil (Fertipro). Embryos were cultured in a humidi-
ﬁed atmosphere at 37 1C and 5% CO2 in air. Embryos that were of
good quality with no signiﬁcant fragmentation or lysis were used
in subsequent experiments.
Immunohistochemistry of human preimplantation embryos
Embryos were placed directly in 4% paraformaldehyde and ﬁxed
for either 30 min at room temperature or overnight at 4 1C on a
rotating shaker. Embryos were then transferred through several
washes of 1X PBS plus 0.1% Tween-20 (PBS/0.1% T) to remove
residual paraformaldehyde. Embryos were placed in PBS/1% T over-
night on a rotating shaker at 4 1C for permeabilization. A longer
permeabilization step was necessary to facilitate the detection of
nuclear antigens; given the thickness of the human zona pellucida
compared to the mouse. Embryos were blocked for 1 h at room
temperature in blocking solution (10% serum diluted in PBS/0.1–0.5%
T). Embryos were placed in primary antibodies at a concentration of
1:500 in blocking solution overnight at 4 1C on a rotating shaker
(antibodies used in this study are listed in Supplementary Table 1).
On the following day, embryos were transferred through several
washes of PBS/0.1% T then placed in a last wash for 30min. Secondary
antibodies (Cy3, FITC or Cy5 donkey anti-rabbit, mouse or goat,
Invitrogen) were diluted in blocking solution at 1:300 concentration.
Embryos were placed in secondary antibody for 1 h at room
temperature on a rotating shaker, transferred through several washes
of PBS/0.1% T and placed in a last wash for 30 min. Embryos were
placed in a 50 ml 1:3 dilution of Vectashield containing DAPI (Vector
Labs): PBS/0.1% T on a coverslip bottom dish (MatTek) for confocal
imaging.
Imaging and analysis
Laser scanning microscopy was performed using a Zeiss
LSM 510 confocal microscope with META software and optical
sections obtained every 1–3 mm with a pinhole diameter of
o2 Airy units. 25X and 40X oil-immersion objectives and 405,
488, 543 and 633 nm lasers were used. Cell numbers were
counted using the IMARIS cell imaging software (Bitplane AG,
Versions 5.7 and 6.0) and ImageJ using the Cell Counter Plugin.
DAPI or transcription factor-stained nuclei were determined
either visually or by segmentation using 3D reconstructions
with isosurface areas of 5–10 mm (depending on the nucleus
size) with background subtraction. Unmodiﬁed images were
used for cell counting and nuclei were considered positive if
the intensity was above cytoplasmic staining. Co-staining was
determined by marking spots in one channel that co-localized
with a DAPI spot. The images in some of the ﬁgures were
modiﬁed by performing contrast and brightness enhancement
using Abode Photoshop CS2.
Blastocyst outgrowths
Human embryos cultured to 6 dpf were used for blastocyst
outgrowth experiments. The zona pellucida was dissolved using
Acidic Tyrode’s Solution (Sigma) and embryos were washed in
Global Media then plated on a feeder layer of gamma-irradiated
mouse embryonic ﬁbroblasts (MEFs) isolated from 12.5 dpf
embryos and passaged three times before irradiation, in HUES cell
derivation media. HUES cell derivation media consisted of 75% KO-DMEM (Invitrogen), 10% KO-SR replacement (Invitrogen), 10%
Plasmanate (Talecris), 2.5% embryonic stem cell tested Fetal Bovine
Serum (FBS) (Hyclone), 2 mM Glutamax-I, 1% non-essential amino
K.K. Niakan, K. Eggan / Developmental Biology 375 (2013) 54–64 57acids, 50 units/ml penicillin and 50 mg/ml streptomycin (Invitrogen),
0.1 mM b-mercaptoethanol (Invitrogen), 5 ng/ml bFGF (Invitrogen),
as described previously (Cowan et al., 2004).Results
Embryonic OCT4 expression was initiated at the 8-cell stage and
CDX2 expression followed blastocyst formation
To gain further insight into the mechanism of lineage speciﬁca-
tion in human preimplantation development, we assessed the
expression of key developmental regulators OCT4 and CDX2,
which are functionally required for early mouse development
(Chawengsaksophak et al., 1997; Nichols et al., 1998; Strumpf
et al., 2005). As previously published (Chen et al., 2009), we
thawed donated human in vitro fertilized embryos and selected
those of good-quality (without signiﬁcant lysis or fragmentation)
for analysis of OCT4 and CDX2 expression at deﬁned stages from
the zygote to the blastocyst.
Similar to immunoﬂuorescence results from mouse cleavage
stage embryos (Dietrich and Hiiragi, 2007; Strumpf et al., 2005),
it was unclear whether cytoplasmic staining in human embryos prior
to the 8-cell stage represents speciﬁc signal or background. Consistent
with these previous studies, we considered positive expression only
when nuclear staining was clearly distinguishable from cytoplasmic
staining. OCT4 protein expression was absent or below the level of
detection in human embryos prior to 3 dpf with less than 7-cells
(data not shown). OCT4 protein expression was ﬁrst detectable in the
nuclei of nearly all cells at the 7–8-cell stage (3 dpf), consistent with
the initiation of human EGA (Braude et al., 1988; Tesarik et al., 1988)
(68728%, n¼6, Fig. 1A, B, see Table S2). We observed that OCT4 was
nearly uniformly expressed in the nuclei of all cells up to 4 dpf
(9973%, n¼11, Fig. 1A, B, see Table S2). OCT4 expression remained
high in both the ICM and TE in 5 dpf early-blastocysts between 33
and 128 cells and was downregulated in a subset of TE cells in mid-
blastocysts (90720%, n¼21, Fig. 1A, B, see Table S2). By 6 dpf,
human blastocysts were comprised of approximately 129–256 cells
and nuclear OCT4-high expression was primarily restricted to the ICM
(1075%, n¼17, Fig. 1A, B, see Table S2). Thus, initiation of OCT4
expression is consistent with the timing of human EGA and its
restriction to the ICM is consistent with our previous study suggesting
a correlation with the optimal time for hESC derivation at 6 dpf (Chen
et al., 2009).
We also performed a detailed time-course analysis of the expres-
sion of CDX2, which is initiated in mouse embryos prior to the
formation of a blastocyst (Dietrich and Hiiragi, 2007; Ralston and
Rossant, 2008; Strumpf et al., 2005) and has been suggested to specify
the TE lineage (Jedrusik et al., 2008, 2010). In contrast to the mouse,
we observed that CDX2 protein was not appreciably expressed in
human 8-cell and morula stage embryos at 3–4 dpf (n¼13, Fig. 1A, B,
see Table S2) and was ﬁrst detectable in embryos at 5 dpf where itsFig. 2. NANOG expression is restricted to the human inner cell mass prior to OCT4
embryo at 5 days post-fertilization (dpf). OCT4 (green), NANOG (red) and DAPI (blue)expression was localized to the TE of blastocysts with a discernable
blastocoel cavity (59733%, n¼10, Fig. 1A, B, Table S1). CDX2
expression overlapped with the expression of OCT4 in nearly all TE
cells at 5 dpf (9776%, n¼6, Fig. 1A, B, see Table S2) and by 6 dpf, the
human blastocyst was comprised largely of CDX2 expressing TE cells
(79714%, n¼12, Fig. 1A, B, see Table S2). It was unclear whether
CDX2 expression between 5 and 6 dpf was lost, reduced or apparently
reduced due to confocal optical sectioning. We used IMARIS cell
imaging software to quantify the intensity of CDX2 expression in
trophectoderm cells at 5 versus 6 dpf in all optical sections. This
analysis suggests that while the proportion of CDX2 expressing cells
per DAPI stained nuclei was not signiﬁcantly different (Fig. 1B) and
that CDX2-high cells were present at these two stages, there were
more cells with moderate or weak CDX2 expression at 6 dpf (Fig. 1A).
We estimate that there were between 1 and 2 cell divisions from the
35-cell embryo, when CDX2 expression was ﬁrst observed, to the
130-cell embryo, when we ﬁrst observed OCT4-high restriction to
the ICM (see Table S2). This suggests that the restriction of OCT4-high
expression to the ICM is likely to be the result of factors downstream
of CDX2 expression, which is consistent with observations made in
mouse, pig and cow embryos (Dietrich and Hiiragi, 2007; Kuijk et al.,
2008; Pant and Keefer, 2009; Ralston and Rossant, 2008).
NANOG expression has been previously shown to be restricted
to epiblast progenitor cells within the ICM prior to OCT4 in
mouse, cow, pig and rhesus monkey embryos (Dietrich and
Hiiragi, 2007; Harvey et al., 2009; Kuijk et al., 2008; Pant and
Keefer, 2009). To further investigate pluripotency gene expression
patterns we analyzed early blastocysts for the expression of
NANOG (Fig. 2). As expected, at 4 dpf in a 44-cell embryo we
found that OCT4 is uniformly expressed in all DAPI-positive cells
(Fig. 2). We observed that NANOG was indeed expressed in
human preimplantation embryos and its expression was
restricted to the ICM earlier than OCT4 (Fig. 2). We did not ﬁnd
evidence of NANOG localization in the TE at this cell stage (Fig. 2)
or later in 6 dpf embryos (data not shown). The restriction of
NANOG expression within the ICM, prior to OCT4, is consistent
with previous reports (Cauffman et al., 2009; Kimber et al., 2008;
Roode et al., 2012), suggesting a conserved expression pattern for
these functionally important pluripotency-associated genes.
SOX17 was heterogeneously expressed in the early human ICM and
was eventually restricted to putative PE cells, where it largely co-
localized with GATA6
In the mouse ICM, mosaic expression of Nanog and Gata6/
Sox17 eventually resolves in the restriction of Gata6 and Sox17
expression to the PE, underlying Nanog expressing epiblast
progenitor cells (Artus et al., 2011; Chazaud et al., 2006; Morris
et al., 2010; Niakan et al., 2010; Plusa et al., 2008). GATA6, GATA4
and SOX17 protein expression has been identiﬁed in putative PE
cells in human mid- to late-blastocysts (Kuijk et al., 2012;
Roode et al., 2012). However, it is unclear whether PE-associate. Optical section and 3D projection of an immunostained human preimplantation
nuclear staining. Scale bar is 100 mm.
Fig. 3. SOX17 is initially heterogeneously expressed and eventually restricted
to human primitive endoderm cells where OCT4 is downregulated. (A) Optical
sections and 3D projections of immunostained human preimplantation embryos
at deﬁned stages of development. The number of days post-fertilization (dpf) and
the approximate cell number is indicated for each embryo. OCT4 (green), SOX17
(red) and DAPI (blue) nuclear staining. Scale bar is 100 mm. White arrows indicate
SOX17-high expressing cells that have down-regulated OCT4 expression within
the inner cell mass. (B) Quantiﬁcation of the total number of OCT4 (dark blue bar)
and SOX17 (medium blue bar) expressing cells as a percentage of total DAPI-
expression. The percentage of SOX17 expressing cells that overlap with the
expression of OCT4 is indicated by the light blue bar. Data are the mean7standard
deviation of biological replicates.
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neously expressed within the early human ICM and are coin-
cidentally expressed within all or a subset of putative human
PE cells.
We assessed the emergence of human PE cells by performing a
detailed time-course immunoﬂuorescence analysis of SOX17
expression from the zygote to the blastocyst. SOX17 was initially
detectable in a 32-cell early-blastocyst (n¼1) (Fig. 3A, B, see Table
S2), but not in human embryos prior to this stage (Fig. 3A, B). At
5 dpf, SOX17 was highly expressed in the nuclei of a subset of
cells that line the blastocoel cavity as well as cells deeper within
the ICM (877%, n¼10, Fig. 3A, B, see Table S2) consistent with
the heterogeneous pattern previously observed for PE-associated
genes during mouse preimplantation development (Artus et al.,
2011; Chazaud et al., 2006; Morris et al., 2010; Niakan et al.,
2010; Plusa et al., 2008). SOX17 expression at 5 dpf largely
overlapped with OCT4 expression in the ICM, though we observed
that an embryo at this stage had begun to down-regulate OCT4
expression in a subset of cells (SOX17þ/OCT4þ overlap: 9876%,
n¼10, Fig. 3A, B, see Table S2). In fully expanded 6 dpf blasto-
cysts, SOX17 expressing cells were restricted to the putative PE
within the ICM (472%, n¼13, Fig. 3A, B, see Table S2). While the
majority of SOX17 expressing cells also expressed high levels of
OCT4 at 6 dpf, a subset of SOX17 expressing putative PE cells had
downregulated OCT4 (SOX17þ/OCT4þ overlap: 90723%, n¼9,
Fig. 3A white arrows, B, see Table S2). Intriguingly, loss of OCT4
expression in the ICM has been observed in mouse embryos at the
late-blastocyst and peri-implantation stage (4.5 dpf), which cor-
relates with commitment of PE cells (Grabarek et al., 2012). Our
observation that human preimplantation embryos downregulate
OCT4 expression in the PE (Fig. 3A, white arrows), similar to late-
or peri-implantation mouse blastocysts, suggests that the human
PE is committed at this stage.
While Gata6 expression is initially more broadly expressed in
the mouse embryo, in the late-blastocyst Gata6 and Sox17
expressing cells are restricted to in the PE adjacent to the
blastocoel cavity (Artus et al., 2011; Morris et al., 2010; Niakan
et al., 2010). To assess the overlap of PE-associated protein
expression we performed immunoﬂuorescence analysis of GATA6
and SOX17 in human 6 dpf blastocysts. Surprisingly, we found
that while GATA6 expression was detectable in the majority of
SOX17 expressing cells in the PE, we also observed a few cells
within the human ICM that expressed SOX17, but not GATA6
(Fig. 4, white arrows). This suggests that PE lineage speciﬁcation
may be distinct in human embryos compared to the mouse.
The inhibitory interactions between Sox17/Gata6 and Nanog
that initiate a cell-sorting process compartmentalizing the ICM into
distinct PE and epiblast domains is thought to be facilitated by
speciﬁc expression of cell-surface proteins, including Laminin,
which has been hypothesized to confer an adherence
difference to cells fated for the PE (Chazaud et al., 2006; Niakan
et al., 2010; Yamanaka et al., 2006). To determine whether this
mechanism is conserved in humans we performed immunoﬂuor-
escence analysis of Laminin expression in human blastocysts. We
observed that Laminin protein is most highly expressed in the
human TE (Fig. 5), consistent with Laminin localization in the
mouse TE (Niakan et al., 2010). However, unlike the mouse, human
ICM cells lacked appreciable Laminin expression in the PE,
suggesting that there may be fundamental differences in the
mechanism of PE lineage speciﬁcation.
Human blastocysts expressed CK7 and FGFR1 in the TE
It has been demonstrated that proteins such as Cdx2 and the ETS-
related transcription factor, Elf5 are initially expressed in the mouse
TE and maintain their expression in later post-implantationtrophoblast progenitor cells (Beck et al., 1995; Ng et al., 2008).
Recently, it has been demonstrated that these factors are conserved
in their expression in human ﬁrst trimester trophoblast cells
(Hemberger et al., 2010). However, some proteins that are expressed
Fig. 4. Overlap of GATA6 and SOX17 expression in the majority of human primitive endoderm cells. Optical sections and 3D projections of immunostained human
preimplantation embryos at deﬁned stages of development. The number of days post-fertilization (dpf) and the approximate cell number is indicated for each embryo.
GATA6 (green), SOX17 (red) and DAPI (blue) nuclear staining. White arrows indicate SOX17-high expressing cells that have down-regulated GATA6 expression within the
primitive endoderm. Scale bar is 100 mm.
Fig. 5. Laminin is highly expressed in human trophectoderm, but not in primitive endoderm cells. Optical sections and 3D projections of immunostained human
preimplantation embryos at deﬁned stages of development. The number of days post-fertilization (dpf) and the approximate cell number is indicated for each embryo. Cell
surface Laminin (green) and SOX17 (red) and DAPI (blue) nuclear staining. Scale bar is 100 mm.
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allele HLA-G, are not expressed in preimplantation human embryos
(Hiby et al., 1999). This suggests that while there is some overlap in
the expression of pre- and post-implantation extraembryonic-asso-
ciated proteins, there are notable differences. We were interested in
determining the preimplantation expression of cytokeratin 7 (CK7),
an intermediate ﬁlament protein whose expression is a basic require-
ment used to identify post-implantation human trophoblast progeni-
tor cells (King et al., 2000).
As expected, we observed that CK7 was highly expressed in the TE
of human blastocysts prior to implantation (Fig. 6A). CK7 expression
is consistent with the utility of this protein as a marker of TE
progenitor cells. Together with the Laminin expression described
above, this suggests that human TE cells have a cell surface and
cytoplasmic composition that is distinct from ICM cells. Fibroblast
growth factor receptor-1 (FGFR1) is also enriched in human ﬁrst-
trimester trophoblast progenitor cells (Anteby et al., 2005), however,
its expression has not been reported in preimplantation human
embryos. Using a well-characterized antibody with no cross-
reactivity to FGFR2, FGFR3 or FGFR4 (Larocca et al., 1998), we
observed that FGFR1 was initially expressed in the majority of TE
cells in human blastocysts. Interestingly, we also observed that FGFR1
expression was eventually restricted to polar TE cells directly adjacent
to the ICM in human embryos with greater than 164-cells (Fig. 6B).
This expression pattern suggests that there are distinct populations of
FGFR1-high polar TE cells compared to FGFR1-low mural TE cells.Fig. 6. Markers of post-implantation trophoblast progenitor cells are expressed
immunostained human preimplantation embryos at deﬁned stages of development.
indicated for each embryo: (A) Intracellular Cytokeratin 7 (CK7) (green) and SOX17 (re
either OCT4 or SOX17 (red) and DAPI nuclear staining. Scale bar is 100 mm.Human blastocyst outgrowths predominantly expressed
extraembryonic-associated proteins, which negatively inﬂuenced
hESC derivation efﬁciency
The derivation of hESCs from preimplantation blastocysts is
most commonly performed by isolating the ICM away from
surrounding TE cells either by immunosurgery or laser-
mediated ablation (Chen et al., 2009). This has been estimated
to improve derivation efﬁciency of hESCs from 8.5 to 10%
when intact blastocysts were used versus 14–58% following
ICM isolation (Chen et al., 2009). The consequence of leaving
the TE intact and plating the whole blastocyst has not been
fully investigated, including the identity of cells that can
emerge at the earliest time-points during derivation. Moreover,
it remains unclear whether extraembryonic stem cell lines may be
established from plating whole blastocysts in these conditions.
To determine the identity of cells that initially proliferated in
the outgrowth of intact blastocysts, we performed immunoﬂuor-
escence analysis of OCT4 as well as extraembryonic-associated
proteins following 4–5 days of in vitro culture under
conventional hESC conditions (n¼5, Fig. 7) (Chen et al., 2009;
Cowan et al., 2004; Thomson et al., 1998). Strikingly, we found
that the majority of cells in the outgrowths robustly expressed
CK7 (Fig. 7) suggesting that TE cells from human blastocysts do
have the ability to proliferate somewhat during in vitro culture,
although these cells could not be maintained (data not shown).in human preimplantation embryos. Optical sections and 3D projections of
The number of days post-fertilization (dpf) and the approximate cell number is
d) and DAPI nuclear staining. (B) Cell surface and intracellular FGFR1 (green) and
Fig. 7. A subset of human blastocyst outgrowths express proteins associated with primitive endoderm and trophectoderm cells. (A) Experimental design: the zona
pelucida (ZP) of human blastocysts were removed by treatment with Acidic Tyrode’s (AT) solution. Whole blastocysts with both the inner cell mass (ICM) and
trophectoderm (TE) were plated under human embryonic stem cell (hESC) derivation conditions for 5 days (on mouse embryonic ﬁbroblasts (MEFs) in the presence of
bFGF). The majority of cells in the outgrowths were CK7-expressing TE cells (green). (B) Outgrowths following 4–5 days of in vitro culture were ﬁxed and
immunoﬂuorescently analyzed for the expression of SOX17 (red) and CDX2 (green) or OCT4 (green) and Cytokeratin-7 (CK7) (green) with DAPI nuclear staining (blue).
Scale bar is 100 mm.
K.K. Niakan, K. Eggan / Developmental Biology 375 (2013) 54–64 61We found that the expression of OCT4 was very rarely observed in
the outgrowth of blastocysts and most outgrowths lacked OCT4
expression altogether (Fig. 7). These observations conﬁrmed the
previous suggestions that derivation from intact blastocysts is
detrimental to hESC derivation efﬁciency.
We also observed that under these conditions very few cells
expressed SOX17, which presumably originated from the PE (Fig. 7).
Similarly, only a few of the cells in the outgrowths expressed CDX2,
which suggests that the majority of TE cells under these conditions
have lost the capacity to retain a key gene associated with TE
progenitor cells (Fig. 7). The lack of sustained SOX17 and CDX2
expression in these early outgrowths suggests that these culture
conditions are not suitable for the establishment of extraembryonic
stem cell lines.Discussion
We have undertaken a detailed immunoﬂuorescence ana-
lysis of human preimplantation embryos from the zygote to
the blastocyst for the appearance and localization of lineage-
speciﬁc transcription factors OCT4, CDX2 and SOX17 (sum-
marized in Fig. 8). Some of our observations conﬁrmed the
expression pattern suggested from investigation of othermammalian embryos, including cows (Berg et al., 2011) where
CDX2 was detectable in the TE following cavitation. By con-
trast, Cdx2 expression was detectable in the mouse morula
prior to cavitation (Dietrich and Hiiragi, 2007; Ralston and
Rossant, 2008; Strumpf et al., 2005), suggesting that TE line-
age segregation may be distinct in humans and cows com-
pared to mice. As regionalized activity of Tead4 in cleavage-
stage embryos is thought to function upstream of Cdx2 in the
mouse embryo (Nishioka et al., 2009; Yagi et al., 2007) it will
be important to determine whether human TE speciﬁcation
requires the same pathway and whether additional lineage
associated genes are conserved or divergent in their expres-
sion in the developing TE (i.e. GATA3, EOMES and FGFR2) or PE
(i.e. GATA4, PDGFRa) by analysis throughout human preim-
plantation development.
We conﬁrmed the previous studies demonstrating that SOX17
was restricted to the putative PE by 7 dpf (Roode et al., 2012).
Signiﬁcantly, we showed for the ﬁrst time that, similar to mouse
embryos, human embryos initially exhibited heterogeneous SOX17
expression within the early ICM with eventual restriction to the PE
lining the blastocoel cavity. Human embryos, like the mouse, also
initially expressed GATA6 and OCT4 more broadly throughout the
embryo (Chen et al., 2009; Kimber et al., 2008; Roode et al., 2012) and
this investigation. However, lack of appreciable Laminin expression in
Fig. 8. Schematic summary of the distribution of lineage-speciﬁc transcription
factors in mouse versus human embryos. Although maternal Oct4 transcript and
protein was expressed from the zygote stage (Palmieri et al., 1994), zygotic Oct4
(green) protein was initially detectable above background in the 8-cell mouse
embryos (data based on Palmieri et al., 1994; Liu et al., 2004). Similarly human
embryos initiate OCT4 (green) expression at the 8-cell stage following embryo
genome activation. In both humans and mice, Oct4/OCT4 was persistently
expressed in the trophectoderm (TE) and eventually restricted to the ICM in
mid-blastocysts. Oct4/OCT4 protein was further restricted to epiblast progenitor
cells within the ICM of human and mouse late-blastocysts, just prior to implanta-
tion into the maternal uterus. In mice, Cdx2 initially exhibits mosaic expression at
the 16-cell stage (shades of blue represent strong (dark blue), weak (light blue) or
absent (gray) expression) and was eventually uniformly expressed in all TE cells
(data based on Dietrich and Hiiragi, 2007; Strumpf et al., 2005). CDX2 expression
in human embryos was initiated after blastocyst formation and in the late-
blastocyst there was variable CDX2 expression in the TE. Sox17 was initially
detectable in the mouse morula, heterogeneously expressed in the early- to mid-
blastocyst and eventually restricted to the PE (data based on Niakan et al., 2010;
Morris et al., 2010; Artus et al., 2011). In humans, SOX17 expression was initially
detectable in the early-blastocysts, heterogeneously expressed in mid-blastocysts
and restricted to most putative PE cells.
K.K. Niakan, K. Eggan / Developmental Biology 375 (2013) 54–6462the presumptive PE and downregulation of GATA6 in a subset of
SOX17 expressing cells suggest that the mechanism of human PE
speciﬁcation may be distinct in humans compared to mice. Moreover,
recent analyses of human embryos treated with FGF/Erk signaling
inhibitors suggest that the PE may segregate by mechanisms distinct
from mouse, rat and cow embryos (Kuijk et al., 2012; Nichols et al.,
2009; Roode et al., 2012; Yamanaka et al., 2010). Therefore, despite
conserved expression of some lineage-speciﬁc transcription factors in
early human embryogenesis, the mechanism for PE and TE speciﬁca-
tion is unknown and may be distinct compared to other species.
We observed downregulation of OCT4 expression in a subset of
SOX17-high expressing human ICM cells at 6 dpf, suggesting that
these are committed PE cells. OCT4-low expression in SOX17- and
GATA4-high putative PE cells has also been noted in human
embryos at 7 dpf (Roode et al., 2012). In the mouse, while Oct4
transcripts are reduced in the PE, Oct4 protein has been suggested
to be more abundantly express in early migrating PE cells (Palmieri
et al., 1994). By 4.5 dpf late-blastocyst, peri-implantation or
implantation-delayed mouse embryos no longer express Oct4 in
the PE, which correlates with a restriction in potency (Grabarek
et al., 2012). Altogether, this suggests that human mid- to late-
blastocysts exhibit an expression pattern that is more analogous to
late-blastocyst or peri-implantation mouse embryos, when thethree embryonic lineages have diverged. It is possible that further
restriction of OCT4 to putative epiblast progenitor cells within the
human ICM restricts the nature of the pluripotent stem cell lines
that can be derived. It will be important to determine whether by
6 dpf epiblast cells within the human ICM are molecularly similar
to pre- or post-implantation mouse epiblast cells or are distinct
and whether this has consequences for the nature of pluripotent
stem cells that can be derived.
In the mouse, Nanog expression is downregulated at the
time of implantation (Chambers et al., 2003; Grabarek et al.,
2012). It will therefore be important to assess whether
NANOG expression is also downregulated in the human late-
blastocyst as this would further suggest that human embryos
share molecular characteristics with the late-blastocyst or peri-
implantation mouse embryo. Signiﬁcantly, in contrast to
mouse, rat and cow, NANOG and GATA4 expression within
the human ICM was unaffected by FGF, MEK and/or Erk
signaling inhibition (Kuijk et al., 2012; Roode et al., 2012),
suggesting that this signaling pathway may be not be required
for the derivation of pluripotent stem cells from human
embryos and that alternative pathways may be responsible
for epiblast and PE speciﬁcation. Our observation that human
embryos at 6 dpf resemble late-blastocyst, peri-implantation or
implantation-delayed mouse embryos suggests that deriving
hESCs similar to mESCs may require both novel culture
conditions and derivation from embryos at an earlier
developmental stage. Alternatively, the type of stem cells that
can be derived from human versus mouse embryos may reﬂect
intrinsic genetic differences between these species, as is sug-
gested by the type of induced pluripotent stem cells that can be
derived from mouse versus human ﬁbroblasts (Takahashi et al.,
2007; Takahashi and Yamanaka, 2006). Currently only one type
of hESC has been derived which more closely resembles post-
implantation mouse epiblast (Brons et al., 2007; Tesar et al.,
2007). Further understanding human embryogenesis will sig-
niﬁcantly improve the utility of human embryos or adult cells
by expanding the repertoire of pluripotent stem cells which
may be distinct in their differentiation efﬁciency or potential,
as recently demonstrated for pre- versus post-implantation
derived mouse stem cells (Cho et al., 2012).
We investigated the consequence of leaving extraembryonic
cells intact during conventional hESC derivation by plating whole
blastocysts. Our results suggest that the negative correlation with
hESC derivation efﬁciency is likely due to the presence of primarily
CK7-expressing TE-like cells, which we are presently unable to
maintain indeﬁnitely in culture. It will be interesting to determine
whether human embryos cultured in alternative conditions or at
earlier stages of development prior to TE speciﬁcation could
facilitate the establishment of extraembryonic stem cell lines.
Our study could therefore also facilitate future attempts to estab-
lish models of human placental cells, which would be of signiﬁcant
importance for further elucidating mechanisms of early human
extraembryonic development and to model human placental
defects. In all, there is a need to further understand the molecular
basis of cell fate speciﬁcation in human embryogenesis compared
with other species as these investigations have importance for
improving assistant reproduction technology and stem cell based
regenerative medicine (Rossant, 2011).
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